273 related articles for article (PubMed ID: 8498881)
1. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
Schmidt PJ; Grover GN; Rubinow DR
Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
[TBL] [Abstract][Full Text] [Related]
2. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
[TBL] [Abstract][Full Text] [Related]
3. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
Smith S; Rinehart JS; Ruddock VE; Schiff I
Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
[TBL] [Abstract][Full Text] [Related]
4. Treatment of premenstrual dysphoria with alprazolam. A controlled study.
Harrison WM; Endicott J; Nee J
Arch Gen Psychiatry; 1990 Mar; 47(3):270-5. PubMed ID: 2407209
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.
Canning S; Waterman M; Orsi N; Ayres J; Simpson N; Dye L
CNS Drugs; 2010 Mar; 24(3):207-25. PubMed ID: 20155996
[TBL] [Abstract][Full Text] [Related]
6. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam.
Evans SM; Haney M; Levin FR; Foltin RW; Fischman MW
Neuropsychopharmacology; 1998 Dec; 19(6):499-516. PubMed ID: 9803426
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of placebo responses in medical treatment of premenstrual syndrome.
Freeman EW; Rickels K
Am J Psychiatry; 1999 Sep; 156(9):1403-8. PubMed ID: 10484952
[TBL] [Abstract][Full Text] [Related]
8. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome.
Hahn PM; Van Vugt DA; Reid RL
Psychoneuroendocrinology; 1995; 20(2):193-209. PubMed ID: 7899538
[TBL] [Abstract][Full Text] [Related]
10. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
Doll H; Brown S; Thurston A; Vessey M
J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
[TBL] [Abstract][Full Text] [Related]
11. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
Thys-Jacobs S; Starkey P; Bernstein D; Tian J
Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
[TBL] [Abstract][Full Text] [Related]
12. Prior benzodiazepine exposure and benzodiazepine treatment outcome.
Rickels K; Freeman EW
J Clin Psychiatry; 2000 Jun; 61(6):409-13. PubMed ID: 10901337
[TBL] [Abstract][Full Text] [Related]
13. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study.
Berger CP; Presser B
Obstet Gynecol; 1994 Sep; 84(3):379-85. PubMed ID: 8058235
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
[TBL] [Abstract][Full Text] [Related]
15. A double-blind trial of four medications to treat severe premenstrual syndrome.
Diegoli MS; da Fonseca AM; Diegoli CA; Pinotti JA
Int J Gynaecol Obstet; 1998 Jul; 62(1):63-7. PubMed ID: 9722128
[TBL] [Abstract][Full Text] [Related]
16. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
Cohen LS; Miner C; Brown EW; Freeman E; Halbreich U; Sundell K; McCray S
Obstet Gynecol; 2002 Sep; 100(3):435-44. PubMed ID: 12220761
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.
Cohen LS; Soares CN; Yonkers KA; Bellew KM; Bridges IM; Steiner M
Psychosom Med; 2004; 66(5):707-13. PubMed ID: 15385695
[TBL] [Abstract][Full Text] [Related]
18. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
Wang M; Hammarbäck S; Lindhe BA; Bäckström T
Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
[TBL] [Abstract][Full Text] [Related]
19. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
[TBL] [Abstract][Full Text] [Related]
20. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.
Freeman E; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
